CN113876963B - 一种阿司匹林-二氧化硅缓释体的制备方法 - Google Patents
一种阿司匹林-二氧化硅缓释体的制备方法 Download PDFInfo
- Publication number
- CN113876963B CN113876963B CN202111160143.5A CN202111160143A CN113876963B CN 113876963 B CN113876963 B CN 113876963B CN 202111160143 A CN202111160143 A CN 202111160143A CN 113876963 B CN113876963 B CN 113876963B
- Authority
- CN
- China
- Prior art keywords
- silicon dioxide
- aspirin
- water
- solution
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 261
- 239000000377 silicon dioxide Substances 0.000 title claims abstract description 130
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 80
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims abstract description 64
- 229960001138 acetylsalicylic acid Drugs 0.000 claims abstract description 64
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims abstract description 33
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 18
- 230000004048 modification Effects 0.000 claims abstract description 17
- 238000012986 modification Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000002270 dispersing agent Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 43
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 235000019353 potassium silicate Nutrition 0.000 claims description 30
- 239000007864 aqueous solution Substances 0.000 claims description 29
- 239000012065 filter cake Substances 0.000 claims description 19
- 238000001291 vacuum drying Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 9
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 239000003607 modifier Substances 0.000 claims description 2
- 230000020477 pH reduction Effects 0.000 claims description 2
- 238000003892 spreading Methods 0.000 claims description 2
- 230000007480 spreading Effects 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 9
- 239000004115 Sodium Silicate Substances 0.000 abstract description 3
- 238000005054 agglomeration Methods 0.000 abstract description 3
- 230000002776 aggregation Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 3
- 229910052911 sodium silicate Inorganic materials 0.000 abstract description 3
- 239000003814 drug Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 229940079593 drug Drugs 0.000 description 21
- 238000010521 absorption reaction Methods 0.000 description 17
- 239000003921 oil Substances 0.000 description 15
- 239000011148 porous material Substances 0.000 description 13
- 238000001179 sorption measurement Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 8
- 238000011068 loading method Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000009850 completed effect Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 239000012808 vapor phase Substances 0.000 description 4
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 238000011085 pressure filtration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PFJFNQUFMTYCHB-UHFFFAOYSA-N C[SiH2]N[SiH3] Chemical compound C[SiH2]N[SiH3] PFJFNQUFMTYCHB-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000008268 response to external stimulus Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- AAPLIUHOKVUFCC-UHFFFAOYSA-N trimethylsilanol Chemical compound C[Si](C)(C)O AAPLIUHOKVUFCC-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
- C07F7/0838—Compounds with one or more Si-O-Si sequences
- C07F7/0872—Preparation and treatment thereof
- C07F7/0874—Reactions involving a bond of the Si-O-Si linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111160143.5A CN113876963B (zh) | 2021-09-30 | 2021-09-30 | 一种阿司匹林-二氧化硅缓释体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111160143.5A CN113876963B (zh) | 2021-09-30 | 2021-09-30 | 一种阿司匹林-二氧化硅缓释体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113876963A CN113876963A (zh) | 2022-01-04 |
CN113876963B true CN113876963B (zh) | 2023-07-25 |
Family
ID=79004681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111160143.5A Active CN113876963B (zh) | 2021-09-30 | 2021-09-30 | 一种阿司匹林-二氧化硅缓释体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113876963B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702245A (zh) * | 2012-06-20 | 2012-10-03 | 中国科学院上海硅酸盐研究所 | 一种疏水性介孔纳米材料及其制备方法和应用 |
CN104188917A (zh) * | 2014-09-11 | 2014-12-10 | 天津市职业大学 | 一种可控释放阿司匹林粉剂的制备方法 |
CN107854449A (zh) * | 2017-09-20 | 2018-03-30 | 中山大学 | 一种具有药物控释性能的纳米复合微球及其制备方法和应用 |
CN108793173A (zh) * | 2018-08-01 | 2018-11-13 | 中国科学技术大学 | 一种采用外循环方式常压干燥制备改性二氧化硅气凝胶材料的方法 |
CN112452294A (zh) * | 2020-11-03 | 2021-03-09 | 中山大学附属口腔医院 | 一种介孔孔径可调的介孔二氧化硅颗粒的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2833937B1 (fr) * | 2001-12-26 | 2004-11-12 | Rhodia Chimie Sa | Silices a faible reprise en eau |
US8097269B2 (en) * | 2004-02-18 | 2012-01-17 | Celonova Biosciences, Inc. | Bioactive material delivery systems comprising sol-gel compositions |
-
2021
- 2021-09-30 CN CN202111160143.5A patent/CN113876963B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702245A (zh) * | 2012-06-20 | 2012-10-03 | 中国科学院上海硅酸盐研究所 | 一种疏水性介孔纳米材料及其制备方法和应用 |
CN104188917A (zh) * | 2014-09-11 | 2014-12-10 | 天津市职业大学 | 一种可控释放阿司匹林粉剂的制备方法 |
CN107854449A (zh) * | 2017-09-20 | 2018-03-30 | 中山大学 | 一种具有药物控释性能的纳米复合微球及其制备方法和应用 |
CN108793173A (zh) * | 2018-08-01 | 2018-11-13 | 中国科学技术大学 | 一种采用外循环方式常压干燥制备改性二氧化硅气凝胶材料的方法 |
CN112452294A (zh) * | 2020-11-03 | 2021-03-09 | 中山大学附属口腔医院 | 一种介孔孔径可调的介孔二氧化硅颗粒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113876963A (zh) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106044788B (zh) | 一种粒径可控的二氧化硅空心球纳米材料及其制备方法 | |
Liu et al. | Formation and characterization of natural polysaccharide hollow nanocapsules via template layer-by-layer self-assembly | |
Chen et al. | Cyclodextrin-based metal–organic framework nanoparticles as superior carriers for curcumin: Study of encapsulation mechanism, solubility, release kinetics, and antioxidative stability | |
Wu et al. | Effects of surface coating on the controlled release of vitamin B1 from mesoporous silica tablets | |
Kazemzadeh et al. | Structure-property relationship for different mesoporous silica nanoparticles and its drug delivery applications: A review | |
Qian et al. | Zwitterionic polymer chain-assisted lysozyme imprinted core-shell carbon microspheres with enhanced recognition and selectivity | |
Timin et al. | Preparation and surface properties of mesoporous silica particles modified with poly (N-vinyl-2-pyrrolidone) as a potential adsorbent for bilirubin removal | |
Nguyen et al. | Surface PEGylation of hollow mesoporous silica nanoparticles via aminated intermediate | |
Dement’Eva et al. | A new method for loading mesoporous silica nanoparticles with drugs: Sol–gel synthesis using drug micelles as a template | |
Zhang et al. | Selective binding of heparin oligosaccharides in a magnetic thermoresponsive molecularly imprinted polymer | |
CN111217372B (zh) | 手性介孔核-壳结构二氧化硅纳米粒及其制备方法和应用 | |
CN114276681B (zh) | 多级介孔结构的聚多巴胺微球及其制备方法 | |
CN113425854A (zh) | 一种茴香酸和聚乙烯亚胺修饰的肿瘤靶向介孔二氧化硅纳米粒及制备方法、应用 | |
CN110385427B (zh) | 一种水溶性纳米粒子及其制备方法和应用 | |
Yang et al. | Multifunctional mesoporous silica nanoparticles with different morphological characteristics for in vitro cancer treatment | |
CN113562737B (zh) | 手性结构可调控的介孔二氧化硅纳米粒及其制备方法和应用 | |
CN113876963B (zh) | 一种阿司匹林-二氧化硅缓释体的制备方法 | |
Kapusuz | Sol–gel derived silica/polyethylene glycol hybrids as potential oligonucleotide vectors | |
Kim et al. | Releasing properties of proteins on SBA-15 spherical nanoparticles functionalized with aminosilanes | |
Lee et al. | Comparison of amine-functionalized mesoporous silica particles for ibuprofen delivery | |
Trofin et al. | Synthesis of Crosslinked Microparticles Based on Glycidyl Methacrylate and N‐Vinylimidazole | |
Sánchez-Orozco et al. | β-Cyclodextrin-functionalized mesocellular silica foams as nanocarriers of doxorubicin | |
KR100859763B1 (ko) | 비치환 알킬기, 알케닐기 또는 알키닐기를 함유한 트리알콕시실란을 이용한 실리카 입자 표면의 소수성 제어방법 및 그 실리카 입자 | |
Dolatabadi et al. | Silica xerogel carrier as encapsulating Material for the in-vitro controlled release of montelukast | |
CN112156730B (zh) | 一种高纯度单分散多孔氧化硅球的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230625 Address after: 701-702, Tian'an science and technology exchange center, Panyu energy saving science and Technology Park, 555 Panyu Avenue North, Panyu District, Guangzhou, Guangdong 511400 Applicant after: GUANGZHOU LINGWE TECHNOLOGY CO.,LTD. Applicant after: LENGSHUIJIANG THREE A NEW MATERIAL TECHNOLOGY CO.,LTD. Address before: 701-702, Tian'an science and technology exchange center, Panyu energy saving science and Technology Park, 555 Panyu Avenue North, Panyu District, Guangzhou, Guangdong 511400 Applicant before: GUANGZHOU LINGWE TECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |